NL-OMON28173已完成不适用
A randomised, open, single-blind parallel-group comparison of the efficacy and the tolerability of phenelzine versus antidepressant augmentation with lithium in the treatment of non-responding depressed elderly inpatients.
ZON-MW0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
- J Clin Psychiatry. 2007 Aug;68(8):1177-85.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female inpatient;
- •2. Aged 60 years or older;
排除标准
- •1. Known hypersensitivity to lithium or phenelzine;
- •2. Previous unsuccessful adequate (minimal 15 mg during 4 weeks) treatment with phenelzine or with lithiumaugmentation (minimal serum level of 0.6 mmol/l during 4 weeks);
研究者
相似试验
已完成
不适用
A randomised, double-blind, parallel-group comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatients.NL-OMON2725881
进行中（未招募）
1 期
To evaluate the safety and efficacy of Penthrox® (methoxyflurane) for the treatment of pain during colonoscopyEUCTR2017-003767-35-BGMundipharma Research Limited80
进行中（未招募）
1 期
To evaluate the safety and efficacy of Penthrox® (methoxyflurane) for the treatment of pain during colonoscopyEUCTR2017-003767-35-FIMundipharma Research Limited80
进行中（未招募）
1 期
To evaluate the safety and efficacy of Penthrox® (methoxyflurane) for the treatment of pain during colonoscopyPain relief during colonoscopyEUCTR2017-003767-35-SEMundipharma Research Limited80
进行中（未招募）
不适用
A double-blind, randomised, parallel group study to evaluate the safety, tolerability and efficacy of TAK-475 alone or co-administered with atorvastatin in patients with primary dyslipidemia - Not availableTreatment of patients with primary dyslipidemiaMedDRA version: 7Level: PTClassification code 10058108EUCTR2004-000775-34-CZTakeda Europe R&D Centre Ltd1,500